Mariposa Health Inc. Investment Update
Filed with ASX · · 2 pages · English
Earlier from Bioxyne
- Bioxyne: Amended Appendix 3Y’s for Adjustment to Directors Share Interests
- December 2013 Quarterly update and Appendix 4C
- Expiry of Unquoted Options
- Sale of HI-164OV Hunter Immunology Pty Ltd
- Appendix 4C - September Quarterly
Later from Bioxyne
- Appendix 4C - December Quarterly
- Appendix 4D - Half Yearly Report and Accounts
- Update On Commercialisation Process
- Appendix 4C - March quarterly
- Bioxyne Commences New Clinical Trial
Follow Bioxyne into a list and get an email when it puts out news.
Follow Bioxyne